NewAmsterdam Pharma Co NV (NewAmsterdam Pharma Co NV) Accumulated other comprehensive income (loss) : $4.42 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. NewAmsterdam Pharma Co NV's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was $4.42 Mil.

NewAmsterdam Pharma Co NV's quarterly Accumulated other comprehensive income (loss) increased from Dec. 2022 ($4.42 Mil) to Jun. 2023 ($8.67 Mil) but then declined from Jun. 2023 ($8.67 Mil) to Dec. 2023 ($4.42 Mil).

NewAmsterdam Pharma Co NV's annual Accumulated other comprehensive income (loss) increased from Dec. 2021 ($0.67 Mil) to Dec. 2022 ($4.42 Mil) but then stayed the same from Dec. 2022 ($4.42 Mil) to Dec. 2023 ($4.42 Mil).

NewAmsterdam Pharma Co NV Accumulated other comprehensive income (loss) Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV Accumulated other comprehensive income (loss) Chart

NewAmsterdam Pharma Co NV Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Accumulated other comprehensive income (loss)

0.67

4.42

NewAmsterdam Pharma Co NV Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial			0.67	1.08	4.42	8.67	4.42

NewAmsterdam Pharma Co NV Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

NewAmsterdam Pharma Co NV Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of NewAmsterdam Pharma Co NV's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

NewAmsterdam Pharma Co NV (NewAmsterdam Pharma Co NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (NAS:NAMS) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

KH6:Germany

Address

Gooimeer 2-35, Naarden, NH, NLD, 1411 DC

Website

https://www.newamsterdampharma.com

NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.